Tahseen Mirza - Concepedia

Author

Tahseen Mirza

United States Food and Drug Administration

Also Known As

Tahseen Mirza

Publications

359

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Pfizer (United States)Novartis (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)United States Pharmacopeial Convention

About

Tahseen Mirza is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and analytical chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	254
2	Biochemistry	2	2	97
3	Education	1	1	20
4	Engineering	1	1	20
5	Natural Sciences	1	1	68

Tahseen Mirza

Publications

340

Citations

H-Index

Page 1

	Year	Citations
Determination of captopril in pharmaceutical tablets by anion-exchange HPLC using indirect photometric detection; a study in systematic method development Tahseen Mirza, Henry S.I. Tan Journal of Pharmaceutical and Biomedical Analysis Medicinal ChemistryPharmaceutical ScienceBiochemistryGas ChromatographyMedicine	2001	68
Evaluation of Dissolution Hydrodynamics in the USP, Peak™ and Flat-Bottom Vessels Using Different Solubility Drugs Tahseen Mirza, Yatindra M. Joshi, Qian Liu, Dissolution Technologies MedicineCapillarity PhenomenonPharmaceutical TechnologyDissolution HydrodynamicsBiomedical Engineering	2005	57
Cleaning level acceptance criteria and a high pressure liquid chromatography procedure for the assay of Meclizine Hydrochloride residue in swabs collected from pharmaceutical manufacturing equipment surfaces Tahseen Mirza, Michael J Lunn, F.J. Keeley, Journal of Pharmaceutical and Biomedical Analysis Level Acceptance CriteriaGas ChromatographyMedicineDrug PurityEnvironmental Analytical Chemistry	1999	40
2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome ( <u>Part 1</u> –Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos) Hendrik Neubert, Stephen C. Alley, Anita Lee, Bioanalysis	2021	32
A stability-indicating HPLC assay for metronidazole benzoate Daniel K. Bempong, Ronald G. Manning, Tahseen Mirza, Journal of Pharmaceutical and Biomedical Analysis BiochemistryMedicineMetronidazole BenzoateAnalytical ChemistryLiquid Chromatography	2005	29
2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback ( <u>Part 2A</u> –Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation <u>Part 2B</u> –Regulatory Agencies’ Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine) Susan Spitz, Yan Zhang, Sally Fischer, Bioanalysis	2021	24
Capillary gas chromatographic assay of residual methenamine hippurate in equipment cleaning validation swabs Tahseen Mirza, Ron C George, John R Bodenmiller, Journal of Pharmaceutical and Biomedical Analysis Residual Methenamine HippurateForensic ToxicologyDrug TestValidation SwabsToxicology	1998	21
Commentary on AAPS Workshop Tong Cheng, Susan D’Souza, Jan E. Parker, Pharmaceutical Research Community EngagementDesignProject ManagementEducationEvaluation	2007	20
Comprehensive Validation Scheme for In Situ Fiber Optics Dissolution Method for Pharmaceutical Drug Product Testing Tahseen Mirza, Qian Liu, Richard Vivilecchia, Journal of Pharmaceutical Sciences EngineeringOptical PropertiesMedicineDrug PurityFiber Optic Sensing	2008	20
Use of In Vitro–In Vivo Correlation to Predict the Pharmacokinetics of Several Products Containing a BCS Class 1 Drug in Extended Release Matrices Tahseen Mirza, Srikant Bykadi, Christopher D. Ellison, Pharmaceutical Research Extended Release MatricesPharmacokinetic ModelingPreclinical Drug EvaluationBcs Class 1Pharmacology	2012	19

Page 1